JTWM
UTHR icon

Jackson Thornton Wealth Management’s United Therapeutics UTHR Stock Holding History

Jackson Thornton Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$206K Sell
360
-275
-43% -$137K 0.02% 272
2025
Q4 		$319K Buy
+635
New +$296K 0.03% 182

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Jackson Thornton Wealth Management's UTHR Position: Q1 2026 in Review

Jackson Thornton Wealth Management reduced its United Therapeutics (UTHR) stake by 43% in Q1 2026, selling an estimated $137K and leaving 360 shares worth $206K. The position accounts for 0.02% of the portfolio, ranked #272.

Jackson Thornton Wealth Management first reported a position in UTHR in Q4 2025 and has held it in 2 quarters since. The position peaked at $319K in Q4 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Jackson Thornton Wealth Management held 360 shares of United Therapeutics worth $206K as of Q1 2026.
  • Jackson Thornton Wealth Management sold 275 United Therapeutics shares in Q1 2026, an estimated $137K.
  • United Therapeutics made up 0.02% of Jackson Thornton Wealth Management's portfolio in Q1 2026, its #272 holding.
  • Jackson Thornton Wealth Management first reported a position in United Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Jackson Thornton Wealth Management's United Therapeutics position peaked at $319K in Q4 2025.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Jackson Thornton Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.